National Pediatric Cancer Foundation Report issue

Foundation Phase 1 Phase 2

Organization Overview

First Clinical Trial
2016
NCT02945800
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

National Pediatric Cancer Foundation